secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANGAMO THERAPEUTICS, INC (SGMO)
CIK:        0001001233
Form:       8-K
Filed at:   2026-07-20T20:44:31+00:00
Accession:  0001193125-26-309012
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 1.03, 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Sangamo Therapeutics receives Nasdaq delisting denial; bankruptcy court approves asset sale bidding procedures
--------------------------------------------------------------------------------

- Bankruptcy court approved asset sale bidding procedures; bid deadline Aug 4, auction Aug 10, sale hearing Aug 20.
- Nasdaq Hearings Panel denied listing continuation; company will not appeal; expects Form 25 delisting.
- Stock suspended from Nasdaq since May 5, 2026; currently trades on OTCQB under symbol SGMOQ.
- Company filed Chapter 11 on June 23, 2026; continues as debtor-in-possession under court jurisdiction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1001233/000119312526309012/0001193125-26-309012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1001233/000119312526309012/d125683d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-309012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer